What Is Functional Dyspepsia?
Functional dyspepsia (FD) is a chronic gastrointestinal disorder characterized by symptoms originating in the gastroduodenal region — epigastric pain, postprandial fullness, early satiety, or epigastric burning — in the absence of an organic lesion that explains the symptoms.
It affects between 10% and 20% of the world population and is one of the most common reasons for gastroenterology consultation. Up to 70% of patients who undergo endoscopy for dyspeptic complaints have normal mucosa, configuring functional dyspepsia.
It frequently coexists with irritable bowel syndrome — up to 40% of patients with FD also meet criteria for IBS, reflecting shared pathophysiologic mechanisms in the gut-brain axis.
Sensitive Stomach
FD involves gastric and duodenal hypersensitivity — the stomach perceives normal distension as uncomfortable or painful.
Impaired Accommodation
The gastric fundus does not relax adequately after a meal, causing early satiety and excessive fullness with small portions.
Gut-Brain Axis
Like IBS, FD is classified as a disorder of gut-brain interaction, with central and peripheral components.
Pathophysiology
The pathophysiology of functional dyspepsia involves multiple mechanisms that may coexist to varying degrees in each patient. The main ones include changes in gastric motility, visceral hypersensitivity, and low-grade duodenal inflammation.
Impaired gastric accommodation is a central mechanism. Normally, the gastric fundus relaxes reflexively to accommodate ingested food. In FD, this relaxation is insufficient, resulting in abnormal distribution of food in the stomach and a sensation of fullness with smaller volumes of food.
Duodenal Inflammation and Microbiota
Recent findings have revealed duodenal eosinophilia and increased mast cells in the duodenal mucosa of patients with FD. This low-grade inflammation may sensitize afferent nerves, contributing to visceral hypersensitivity. The role of Helicobacter pylori remains debated — eradication improves symptoms in a minority of patients.
Delayed gastric emptying is present in 20-30% of patients with FD, but the correlation with symptom intensity is weak, suggesting that dysmotility is only one of the contributing factors.
Symptoms
Functional dyspepsia is subdivided into two main subtypes that may coexist: postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS). Each subtype reflects partially distinct pathophysiologic mechanisms.
FUNCTIONAL DYSPEPSIA SUBTYPES
| FEATURE | POSTPRANDIAL DISTRESS SYNDROME | EPIGASTRIC PAIN SYNDROME |
|---|---|---|
| Main symptom | Postprandial fullness and early satiety | Epigastric pain or burning |
| Relation to meal | Triggered by eating | Can occur fasting or postprandial |
| Main mechanism | Impaired gastric accommodation | Acid hypersensitivity |
| Prevalence | More common (~60%) | Less common (~40%) |
| Preferred treatment | Prokinetics | PPIs and neuromodulators |
Symptoms of Functional Dyspepsia
- 01
Postprandial fullness
Sensation of an excessively full stomach after meals of normal volume, which limits the ability to finish the meal.
- 02
Early satiety
Inability to finish a meal of usual size, feeling full after a few bites.
- 03
Epigastric pain
Pain located in the stomach region (epigastrium), which may be burning, squeezing, or stabbing.
- 04
Epigastric burning
Burning sensation in the stomach region, distinct from retrosternal heartburn of reflux.
- 05
Nausea
Present in up to 50% of patients, generally accompanying postprandial fullness.
- 06
Excessive belching
Frequent belching, often from anxiety-associated aerophagia.
Diagnosis
The diagnosis of functional dyspepsia is clinical, based on the Rome IV criteria, after exclusion of organic causes. Upper endoscopy is the main test to rule out ulcers, neoplasms, and esophagitis. Testing for H. pylori is recommended.
In young patients (under 55 years) without alarm signs, an initial approach with H. pylori testing and empirical treatment with a PPI may be considered before endoscopy (the age cutoff varies between 50-60 years depending on the guideline and local context of gastric cancer and H. pylori prevalence). Endoscopy is mandatory when alarm signs are present.
🏥Rome IV Criteria for Functional Dyspepsia
- 1.One or more of the following: postprandial fullness, early satiety, epigastric pain, epigastric burning
- 2.Symptoms present in the last 3 months, with onset at least 6 months ago
- 3.No evidence of structural disease (including endoscopy) that explains the symptoms
- 4.Criteria met for PDS and/or EPS
DIAGNÓSTICO DIFERENCIAL
Diagnóstico Diferencial
Peptic Ulcer
- Burning epigastric pain
- Worsens with fasting (duodenal ulcer)
- Improves with food (gastric ulcer)
- Hematemesis or melena = urgent endoscopy
Testes Diagnósticos
- Upper endoscopy
- H. pylori testing
GERD
Leia mais →- Retrosternal heartburn
- Acid regurgitation
- Worsens when lying down
Testes Diagnósticos
- Esophageal pH monitoring
- Endoscopy
Gastroparesis
- Severe early fullness
- Postprandial vomiting
- DM or prior surgery
Testes Diagnósticos
- Gastric emptying scintigraphy
Gastric Cancer
- New-onset dyspepsia after age 55
- Weight loss
- Dysphagia
- Digestive alarm sign in age >55 = endoscopy
Testes Diagnósticos
- Endoscopy with biopsy
Cholelithiasis
- Right upper quadrant pain after meals
- Fat intolerance
- Nausea
Testes Diagnósticos
- Abdominal ultrasound
Peptic Ulcer and Gastric Cancer: Organic Causes Requiring Endoscopy
Peptic ulcer and functional dyspepsia share postprandial epigastric pain, but ulcer tends to produce more localized and intense pain with a characteristic pattern: duodenal ulcer worsens with fasting and improves with food, while gastric ulcer worsens with intake. Definitive differential diagnosis is made by upper endoscopy, which also detects H. pylori infection — a treatable cause present in approximately 60-80% of duodenal ulcers.
Gastric cancer is the most feared organic cause that presents as dyspepsia. Alarm signs such as involuntary weight loss, progressive dysphagia, persistent vomiting, anemia, and onset of symptoms after age 55 make endoscopy mandatory. The absence of red flags in a young patient allows initial empirical management with a PPI and H. pylori testing, but persistence of symptoms after 4-8 weeks justifies endoscopy regardless of age.
GERD and Gastroparesis: Frequent Overlap with Functional Dyspepsia
Gastroesophageal reflux disease (GERD) and functional dyspepsia coexist in up to 40% of patients — which complicates diagnosis. Retrosternal heartburn, acid regurgitation, and worsening when lying down or bending the trunk are more typical of GERD. The 24-hour esophageal pH study is the most sensitive test to document pathologic reflux. In clinical practice, the therapeutic test with a PPI for 4 weeks is the first step: significant improvement points to GERD; lack of response suggests functional dyspepsia or another cause.
Gastroparesis — delayed gastric emptying — produces severe early fullness, prolonged postprandial fullness, and vomiting of food ingested hours earlier, a picture that overlaps with the postprandial distress subtype of functional dyspepsia (PDS). Poorly controlled diabetes mellitus, prior gastric surgery, and neurologic diseases are risk factors. Gastric emptying scintigraphy with a standardized meal is the confirmatory test and differentiates gastroparesis from pure functional dyspepsia.
Cholelithiasis: When to Think of the Gallbladder
Cholelithiasis (gallstones) causes biliary colic — pain in the right upper quadrant or epigastrium with radiation to the right shoulder, of sudden onset, typically after fat-rich meals, lasting 30 minutes to 6 hours. Although the classic picture is well defined, gallstones frequently coexist with dyspepsia and many patients have atypical symptoms. Abdominal ultrasound is the test of choice, with sensitivity >95% for stones >3 mm.
Importantly, the presence of gallstones does not imply that they are the cause of dyspeptic symptoms. Studies show that cholecystectomy relieves classic biliary colic but does not resolve nonspecific dyspepsia in a large proportion of cases. The physician must carefully assess whether the patient symptoms are compatible with true biliary colic or with coexisting functional dyspepsia — the surgical decision depends on this differentiation.
Treatment
Treatment of functional dyspepsia is directed at the predominant subtype and is escalated according to response. H. pylori eradication, when present, is the first step — eradication provides symptomatic benefit in approximately 10% of infected patients (NNT around 14 for durable response, per Ford et al. Cochrane 2022).
Proton pump inhibitors (PPIs) are effective mainly in epigastric pain syndrome, with a number needed to treat (NNT) of approximately 10. For postprandial distress syndrome, prokinetics such as domperidone may improve symptoms.
Neuromodulators such as low-dose amitriptyline (10-25 mg/day initial, individually titrated — typically 10-50 mg/day as a neuromodulator) have shown superior efficacy to placebo in clinical trials, acting on visceral hypersensitivity and central pain modulation. Mirtazapine may be useful in patients with prominent nausea and weight loss.
Acupuncture as Treatment
Acupuncture is a complementary therapeutic option for functional dyspepsia, with evidence of efficacy in clinical trials. Proposed mechanisms include improvement of gastric accommodation, regulation of gastric emptying, vagal modulation, and reduction of visceral hypersensitivity.
Experimental studies suggest that stimulation of specific acupuncture points can modulate gastric motility through vagal pathways and the autonomic nervous system. Clinical trials in China and Europe report symptomatic relief in some patients compared to sham acupuncture and conventional pharmacotherapy, although methodologic heterogeneity still limits definitive conclusions.
A common protocol involves twice-weekly sessions for 4 weeks, followed by weekly sessions for another 4 weeks. Acupuncture can be used as monotherapy in mild cases or as adjunctive treatment in moderate to severe cases.
Prognosis
Functional dyspepsia is a chronic condition with a fluctuating course. Long-term studies show that approximately 50% of patients have persistent symptoms after 5 years, while 30-40% experience improvement or spontaneous resolution.
There is no evidence that FD progresses to serious organic diseases such as peptic ulcer or gastric cancer. The main long-term consequence is the impact on quality of life, nutritional status, and psychological well-being.
Factors associated with better prognosis include adequate management of anxiety, avoidance of excessive dietary restrictions, treatment adherence, and maintenance of regular physical activity. Treatment response can take weeks to months.
Myths and Facts
Myth vs. Fact
Functional dyspepsia means the person has gastritis.
FD is different from gastritis. Gastritis is inflammation of the gastric mucosa seen on biopsy. In FD, endoscopy and biopsies are normal or show nonspecific changes. They are distinct conditions with different treatments.
Taking omeprazole resolves all cases of dyspepsia.
PPIs are effective in only 30-40% of patients with FD, especially in epigastric pain syndrome. For postprandial distress syndrome, prokinetics and neuromodulators may be more effective.
Stress is the only cause of functional dyspepsia.
Stress is a modulating factor, but FD has pathophysiologic bases including dysmotility, visceral hypersensitivity, microscopic duodenal inflammation, and changes in microbiota. It is not just 'nerves'.
Functional dyspepsia always requires endoscopy.
In young patients without alarm signs, an initial approach with H. pylori testing and empirical treatment may be considered before endoscopy, especially under age 55.
When to Seek Help
Most cases of dyspepsia can be managed with basic guidance, but certain situations require medical evaluation to exclude organic causes.
Frequently Asked Questions about Functional Dyspepsia
Functional dyspepsia is a chronic gastrointestinal disorder characterized by discomfort or pain in the upper abdomen — including epigastric burning, postprandial fullness, early satiety, and nausea — without an organic cause identifiable by endoscopy or imaging studies. It is diagnosed by Rome IV criteria and affects 10-20% of the world population. Despite normal tests, the symptoms are real and result from dysfunction in visceral sensitivity and gastric motility.
Gastritis is a histologic diagnosis: inflammation of the gastric mucosa confirmed by endoscopic biopsy. Functional dyspepsia is a clinical-functional diagnosis, with normal gastric mucosa or with minimal changes that do not correlate with symptoms. Many patients with clinically reported "gastritis" actually have functional dyspepsia. The distinction matters because treatment differs: gastritis caused by H. pylori is treated with bacterial eradication, while functional dyspepsia requires a multimodal approach.
H. pylori is detected in some patients with functional dyspepsia, but its causal relationship is controversial. Guidelines recommend H. pylori testing and eradication in all patients with dyspepsia, since approximately 10% improve symptomatically after treatment — a small but clinically relevant proportion. After confirmed eradication and absence of improvement, the diagnosis of true functional dyspepsia can be established.
Rome IV criteria divide functional dyspepsia into two main subtypes: Epigastric Pain Syndrome (EPS) — characterized by intermittent epigastric pain or burning, generally postprandial or fasting-related; and Postprandial Distress Syndrome (PDS) — marked by uncomfortable postprandial fullness and early satiety. The two subtypes can coexist and guide different therapeutic choices.
High-fat foods delay gastric emptying and worsen postprandial fullness. Caffeine, alcohol, spicy foods, citrus, and carbonated beverages frequently exacerbate symptoms. Large meals and irregular schedules also contribute. The ideal approach is a food diary to identify individual triggers, followed by personalized dietary modification — there is no universal diet for all patients with functional dyspepsia.
Systematic reviews suggest that acupuncture may relieve symptoms of fullness, epigastric pain, and nausea in functional dyspepsia, with results that, in some studies, approach those of prokinetics — without this configuring pharmacologic substitution. Proposed mechanisms include potential influence on gastric emptying, modulation of visceral sensitivity, and effect on the brain-gut axis. Treatment should be conducted by a medical acupuncturist and individualized, with usual protocols of 10-12 sessions, as a complementary option among non-pharmacologic approaches. No pharmacologic interactions described with PPIs, prokinetics, or neuromodulators. Patients with an associated anxiety and stress component may respond better.
PPIs are effective mainly for the EPS subtype (epigastric pain syndrome) and when GERD is associated. For the PDS subtype (fullness and early satiety), prokinetics such as domperidone or metoclopramide tend to be more effective. The response to PPIs in pure functional dyspepsia is modest — about 30-40% of patients improve versus 20-25% with placebo. Continued use of PPIs without clear indication should be avoided.
Yes, in neuromodulating doses (lower than antidepressant doses). Tricyclic antidepressants such as amitriptyline at doses of 10-25 mg/day initially, individually titrated (typically 10-50 mg/day as a neuromodulator) reduce visceral hypersensitivity and improve quality of life in patients with refractory functional dyspepsia, especially with predominant pain. SSRIs are also used. The indication is made by the physician after failure of first-line measures and considers the profile of each patient.
No. Peptic ulcer is a structural lesion — erosion of the gastric or duodenal mucosa — identified by endoscopy, with predominantly infectious (H. pylori) or pharmacologic (NSAIDs) cause. Functional dyspepsia has no identifiable lesion. Clinically, the distinction is not always obvious: both cause epigastric pain. Endoscopy is the test that definitively differentiates the two conditions and is mandatory in the presence of alarm signs.
Seek medical evaluation immediately if you have: involuntary weight loss, difficulty or pain swallowing (dysphagia), persistent or bloody vomiting, dark stools (melena), or anemia. Even without these signs, consult a physician if symptoms persist for more than 4 weeks, impact eating or quality of life, or if you are over 55 with new-onset dyspepsia. Correct diagnosis avoids inappropriate treatments and ensures organic causes are not missed.
Related Reading
Deepen your knowledge with related articles